Published in Ann Neurol on January 01, 2005
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology (2009) 2.47
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Estimating cerebral microinfarct burden from autopsy samples. Neurology (2013) 1.87
The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener (2007) 1.81
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol (2009) 1.69
Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol (2011) 1.65
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain (2013) 1.64
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol (2013) 1.52
AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging (2007) 1.39
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology (2012) 1.34
Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Med (2010) 1.27
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc (2008) 1.20
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol Commun (2013) 1.15
Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol (2010) 1.15
The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment. Curr Alzheimer Res (2012) 1.13
Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther (2014) 1.11
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain (2015) 1.09
Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimers Dement (2011) 1.08
Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol (2005) 1.07
Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging (2008) 1.05
Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03
A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging (2013) 1.02
An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology (2009) 1.01
Toward a pathological definition of vascular dementia. J Neurol Sci (2010) 1.01
Trends in the prevalence of dementia in Japan. Int J Alzheimers Dis (2012) 1.01
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab (2016) 0.98
Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab (2013) 0.95
Neuropathologic correlates of cognition in a population-based sample. J Alzheimers Dis (2013) 0.94
Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis (2011) 0.93
Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92
Characterization of Japanese-American men with a single neocortical AD lesion type. Neurobiol Aging (2007) 0.91
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry (2006) 0.89
Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88
Evolving Concept of Small Vessel Disease through Advanced Brain Imaging. J Stroke (2015) 0.87
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. BMC Psychiatry (2012) 0.87
Alzheimer's disease: pathological mechanisms and recent insights. Curr Neuropharmacol (2011) 0.86
Neuropathology-based risk scoring for dementia diagnosis in the elderly. J Alzheimers Dis (2009) 0.86
Confounding in the Estimation of Mediation Effects. Comput Stat Data Anal (2007) 0.86
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. J Alzheimers Dis (2012) 0.85
Associations of brain lesions at autopsy with polysomnography features before death. Neurology (2014) 0.85
Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia. Neurobiol Aging (2014) 0.85
Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression. J Alzheimers Dis (2012) 0.83
Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Neurodegener Dis Manag (2015) 0.83
Alzheimer's disease and endothelial dysfunction. Neurol Sci (2009) 0.82
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology. Front Neurol (2015) 0.81
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up. J Cereb Blood Flow Metab (2016) 0.81
Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1. Neurobiol Aging (2008) 0.81
Risk perception and preference for prevention of Alzheimer's disease. Value Health (2009) 0.81
Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease. J Alzheimers Dis (2013) 0.80
Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: A systematic review of epidemiologic research. Neurotoxicology (2016) 0.79
White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain (2016) 0.79
The role of cerebrovascular disease when there is concomitant Alzheimer disease. Biochim Biophys Acta (2015) 0.77
AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol (2012) 0.77
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta (2015) 0.76
Prevention of dementia: Role of vascular risk factors and cerebral emboli. Indian J Psychiatry (2009) 0.76
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults. Neuroimage (2016) 0.75
The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters. J Alzheimers Dis (2015) 0.75
Role of brain infarcts in behavioral variant frontotemporal dementia: Clinicopathological characterization in the National Alzheimer's Coordinating Center database. Neurobiol Aging (2015) 0.75
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med (2012) 4.59
Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain (2007) 4.36
Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect (2011) 3.87
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics (2003) 3.84
Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med (2010) 3.81
Increases in alcohol and marijuana use during the transition out of high school into emerging adulthood: The effects of leaving home, going to college, and high school protective factors. J Stud Alcohol (2006) 3.72
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol (2002) 3.54
A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol (2005) 3.49
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: a multicenter, prospective, randomized trial. Ann Surg (2006) 3.34
Results of a type 2 translational research trial to prevent adolescent drug use and delinquency: a test of Communities That Care. Arch Pediatr Adolesc Med (2009) 3.25
Developmental relationships between adolescent substance use and risky sexual behavior in young adulthood. J Adolesc Health (2002) 3.20
Effects of the Seattle social development project on sexual behavior, pregnancy, birth, and sexually transmitted disease outcomes by age 21 years. Arch Pediatr Adolesc Med (2002) 3.14
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
Early effects of Communities That Care on targeted risks and initiation of delinquent behavior and substance use. J Adolesc Health (2008) 3.06
Adolescent substance use outcomes in the Raising Healthy Children project: a two-part latent growth curve analysis. J Consult Clin Psychol (2005) 3.06
Walking and dementia in physically capable elderly men. JAMA (2004) 2.94
Solvent exposures and Parkinson disease risk in twins. Ann Neurol (2011) 2.92
Testing communities that care: the rationale, design and behavioral baseline equivalence of the community youth development study. Prev Sci (2008) 2.85
Family influences on the risk of daily smoking initiation. J Adolesc Health (2005) 2.80
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol (2008) 2.74
Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol (2008) 2.73
Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease. Am J Med (2004) 2.58
Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke (2006) 2.53
Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol (2007) 2.53
Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol (2005) 2.52
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (2004) 2.43
Modeling the Etiology of Adolescent Substance Use: A Test of the Social Development Model. J Drug Issues (1996) 2.34
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26
Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord (2006) 2.26
Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr (2011) 2.21
Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care (2010) 2.14
Promoting positive adult functioning through social development intervention in childhood: long-term effects from the Seattle Social Development Project. Arch Pediatr Adolesc Med (2005) 2.12
Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol (2008) 1.99
Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension (2012) 1.96
Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet (2009) 1.96
Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol (2004) 1.93
Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ (2010) 1.92
Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects. Stroke (2002) 1.90
Writing and reading: connections between language by hand and language by eye. J Learn Disabil (2004) 1.89
Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet (2012) 1.84
Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension (2010) 1.84
Effects of Communities That Care on prevention services systems: findings from the community youth development study at 1.5 years. Prev Sci (2007) 1.80
Adolescent heavy episodic drinking trajectories and health in young adulthood. J Stud Alcohol (2004) 1.74
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology (2012) 1.69
Design and analysis of the Community Youth Development Study longitudinal cohort sample. Eval Rev (2009) 1.67
Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc (2010) 1.65
Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol (2007) 1.65
Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol (2011) 1.65
Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke (2002) 1.64
Listening Comprehension, Oral Expression, Reading Comprehension, and Written Expression: Related Yet Unique Language Systems in Grades 1, 3, 5, and 7. J Educ Psychol (2010) 1.60
Latent growth modeling of the relationship between depressive symptoms and substance use during adolescence. Psychol Addict Behav (2008) 1.60
A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism. J Am Acad Child Adolesc Psychiatry (2002) 1.59
Sustained decreases in risk exposure and youth problem behaviors after installation of the Communities That Care prevention system in a randomized trial. Arch Pediatr Adolesc Med (2011) 1.58
Effects of social development intervention in childhood 15 years later. Arch Pediatr Adolesc Med (2008) 1.58
Growth in phonological, orthographic, and morphological awareness in grades 1 to 6. J Psycholinguist Res (2010) 1.58
Converging evidence for triple word form theory in children with dyslexia. Dev Neuropsychol (2006) 1.57
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol (2004) 1.57
Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol (2009) 1.56